CAS NO: | 375347-20-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Lamotrigine hydrate is a potent and orally activeanticonvulsantor antiepileptic agent. Lamotrigine hydrate selectively blocks voltage-gatedNa+channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine hydrate can be used for the research of epilepsy, focal seizure, et al[1][2]. |
体外研究 (In Vitro) | Lamotrigine hydrate inhibits Veratrine evoked release of glutamate and aspartate with ED50values of 21 μM for both amino acids, but Lamotrigine hydrate is less potent in the inhibition of GABA release (ED50=44 μM. At concentrations up to 300 μM, LTG has no effect on patassium-evoked amino acid[1].Lamotrigine hydrate is some five times less potent in the inhibition of Veratrine-evoked [3H]acetylcholine release (ED50=100 μM) than in glutamate or aspartate release[1]. |
体内研究 (In Vivo) | Lamotrigine hydrate (IP, 30 min before pentylenetetrazol; 10 mg/kg, 15 mg/kg or 20 mg/kg) decreases the seizure intensity at the higher doses, it increases the latency to the first pentylenetetrazol-induced seizure in all studied doses compared with the controls[2]. |
Clinical Trial | |
分子量 | 274.11 |
Formula | C9H9Cl2N5O |
CAS 号 | 375347-20-9 |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |